However, the health products company will face challenges in meeting ambitious growth targets for the new business, and ongoing clinical trials are not certain to produce results that will lead to the wider use of Abiomed’s devices that J&J expects, analysts say. J&J’s medical device business, which sells artificial knees and contact lenses, has seen … Read more
For nearly five years, Houston oil executive Jose Pereira was imprisoned in Venezuela, spending long stretches in solitary confinement in an underground cell, deprived of medication and surviving on chicken scraps and rice. In an interview with The Wall Street Journal, Mr. Pereira said he had lost 100 pounds and survived two bouts of Covid-19 … Read more
Covid vaccines are administered in Miami, August 4. Photo: Marta Lavandier/Associated Press How safe are the Covid-19 vaccines? During my leadership, the Florida Department of Health analyzed the overall mortality and cardiac mortality risk associated with Covid-19 vaccination. We found an 84% increase in the relative incidence of cardiac-related death among men 18 to 39 … Read more
Just because your smartwatch can tell you if you have an irregular heartbeat, does that mean the information will help you? Many new smartwatches, including those from Apple, have sensors that can pick up an irregular heart rate and alert users that they may be in atrial fibrillation, or AFib. The devices hit the market … Read more
A new heart valve repair device from Edwards Lifesciences corp. was as effective as the market-leading device from Abbott Laboratories in a clinical study in heart disease patients, a finding that is likely to intensify competition in a growing device market. Edwards said Thursday that its new product, known as Pascal Precision, had been approved … Read more
More than 200 million people around the world take brand-name statins like Lipitor and Crestor every day to lower their bad cholesterol, known as LDL. Unfortunately, a majority fail to stick to their daily pills, putting them at risk for heart disease. A biotech company formed by one of the top heart disease experts wants … Read more
The once-lucrative heart medicine market is now poised to make a comeback, but at the cost of major investments in research and deal-making. After watching cheaper generics seize sales of once-high-flying blood pressure, cholesterol and other heart drugs, companies scrambled to find substitutes and then win reimbursement at five-figure prices. Drug manufacturers are now launching … Read more
A cancer treatment revolution that started in the 1980s is spreading to heart care. In the 1980s, cancer was treated almost exclusively in hospitals. These days, more than 80% of all cancer treatment takes place in municipal outpatient clinics, which achieve better results, keep costs low and offer a more comfortable environment for both patients … Read more
Two brain-dead individuals received genetically modified pig heart transplants as part of growing efforts by scientists seeking to improve swine virus experiments on pigs and collect data that could help start clinical trials on animal-to-human organ transplants. Researchers at NYU Langone Health, where the research studies took place in June and July, said the pig … Read more
US health authorities approved a pill from Bristol-Myers Squibb Co., which is the first to treat people with the most common genetic heart disease. The Food and Drug Administration approved the drug for people who show symptoms of the condition, which can lead to blood clots, strokes and, in rare cases, death, Bristol said Thursday.